Tenecteplase (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tenecteplase" in English language version.

refsWebsite

Global rank English rank

4^th place

1^st place

447^th place

338^th place

2^nd place

102^nd place

76^th place

11^th place

8^th place

doi.org

Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. (March 2012). "A randomized trial of tenecteplase versus alteplase for acute ischemic stroke". The New England Journal of Medicine. 366 (12): 1099–1107. doi:10.1056/NEJMoa1109842. hdl:1959.13/1039697. PMID 22435369.{{cite journal}}: CS1 maint: overridden setting (link)
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. (December 2019). "Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. 50 (12): e344 – e418. doi:10.1161/str.0000000000000211. PMID 31662037. S2CID 204973899.{{cite journal}}: CS1 maint: overridden setting (link)

"Tenecteplase Product Approval Information". U.S. Food and Drug Administration (FDA). 3 November 2008. Archived from the original on 19 January 2009. Retrieved 28 February 2025.
"FDA Roundup: March 4, 2025". U.S. Food and Drug Administration. 4 March 2025. Archived from the original on 6 March 2025. Retrieved 7 March 2025.

Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. (March 2012). "A randomized trial of tenecteplase versus alteplase for acute ischemic stroke". The New England Journal of Medicine. 366 (12): 1099–1107. doi:10.1056/NEJMoa1109842. hdl:1959.13/1039697. PMID 22435369.{{cite journal}}: CS1 maint: overridden setting (link)

"Tnkase- tenecteplase kit". DailyMed. 18 December 2024. Retrieved 28 February 2025.
"Tnkase- tenecteplase kit". DailyMed. 10 January 2024. Retrieved 28 February 2025.

Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. (March 2012). "A randomized trial of tenecteplase versus alteplase for acute ischemic stroke". The New England Journal of Medicine. 366 (12): 1099–1107. doi:10.1056/NEJMoa1109842. hdl:1959.13/1039697. PMID 22435369.{{cite journal}}: CS1 maint: overridden setting (link)
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. (December 2019). "Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. 50 (12): e344 – e418. doi:10.1161/str.0000000000000211. PMID 31662037. S2CID 204973899.{{cite journal}}: CS1 maint: overridden setting (link)

"Tenecteplase Product Approval Information". U.S. Food and Drug Administration (FDA). 3 November 2008. Archived from the original on 19 January 2009. Retrieved 28 February 2025.
"FDA Roundup: March 4, 2025". U.S. Food and Drug Administration. 4 March 2025. Archived from the original on 6 March 2025. Retrieved 7 March 2025.